Prot# VCH 916-103: A Phase IB, Multicenter, Randomized, Double-Blinded, and Placebo-Controlled Study of the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of VCH-916 in Treatment Naive Subjects with Chronic Hepa

Project: Research project

Project Details

StatusFinished
Effective start/end date4/17/084/17/11

Funding

  • Duke University (VCH 916-103)
  • Shire ViroPharma Incorporated (VCH 916-103)